Resumo

GARCIA LUQUE, A; PUERRO VICENTE, M; SANCHEZ LOPEZ, P  e  LOPEZ MORAN, MJ. Positive assessment of drugs: September, October and November 2017. Sanid. Mil. [online]. 2018, vol.74, n.1, pp.26-31. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712018000100006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2017, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Benralizumab; Fasenra^®; Human fibrinogen; Human thrombin; VeraSeal^®; Niraparib; Zejula^®; Buprenorphine; Naloxone; Zubsolv^®; Ocrelizumab; Ocrevus^®; Budesonide; Jorveza^®; Bevacizumab; Mvasi^®; Letermovir; Prevymis^®; Fluticasone; Umeclidinium; Vilanterol; Elebrato Ellipta^®; Trelegy Ellipta^®; Guselkumab; Tremfya^®; Nyxoid^®; Padeliporfine; Tookad^®; Prasterone; Intrarosa^®; Rurioctocog Alfa Pegol; Adynovi^®.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )